Zila, Inc.

Zila, Inc., a specialty pharmaceutical company, focuses on the prevention, detection, and treatment of oral diseases, primarily oral cancer. The company offers ViziLite Plus, its flagship product, for early detection of oral abnormalities that could lead to cancer. In addition, Zila designs, manufactures, and markets a suite of proprietary products directly to dental professionals for periodontal disease, including the Rota-dent Professional Powered Brush, the Pro-Select Platinum ultrasonic scaler, and a portfolio of oral pharmaceutical products for both in-office and home-care use. It also engages in the research and development activities, focusing on pre-cancer/cancer detection through its patented Zila Tolonium Chloride and OraTest technologies and is pursuing regulatory approval for the OraTest product as an oral cancer diagnostic system. The company was founded in 1980 and is headquartered in Phoenix, Arizona.